Leblhuber Friedrich, Geisler Simon, Steiner Kostja, Fuchs Dietmar, Schütz Burkhard
Department of Gerontology, Landesnervenklinik Wagner-Jauregg Linz, Wagner-Jauregg Weg 15, 4020, Linz, Austria.
J Neural Transm (Vienna). 2015 Sep;122(9):1319-22. doi: 10.1007/s00702-015-1381-9. Epub 2015 Feb 14.
Fecal concentrations of calprotectin were examined in 22 patients with Alzheimer's disease (AD) and compared with serum concentrations of aromatic amino acids. Calprotectin concentrations were mean ± SEM 140 ± 31.9 mg/kg, 16 patients (73%) presented with concentrations outside normal (>50 mg/kg). Concentrations correlated inversely with serum levels of tryptophan, tyrosine and phenylalanine (all p < 0.05). Increased concentrations of fecal calprotectin indicate a disturbed intestinal barrier function in AD patients which could be of relevance for the lowering of essential aromatic amino acids concentrations in the blood.
对22例阿尔茨海默病(AD)患者的粪便钙卫蛋白浓度进行了检测,并与血清芳香族氨基酸浓度进行了比较。钙卫蛋白浓度平均±标准误为140±31.9mg/kg,16例患者(73%)的浓度超出正常范围(>50mg/kg)。浓度与血清色氨酸、酪氨酸和苯丙氨酸水平呈负相关(均p<0.05)。粪便钙卫蛋白浓度升高表明AD患者肠道屏障功能紊乱,这可能与血液中必需芳香族氨基酸浓度降低有关。